1-[1,3-dioxolan-4-yl-(3-fluorophenyl)methyl]-5-(1-fluoroethenyl)-3,3-dimethyl-4-[(Z)-prop-1-enyl]pyrrol-2-one
C21H23F2NO3 — CID 143635734
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[1,3-dioxolan-4-yl-(3-fluorophenyl)methyl]-5-(1-fluoroethenyl)-3,3-dimethyl-4-[(Z)-prop-1-enyl]pyrrol-2-one
1-[1,3-dioxolan-4-yl-(3-fluorophenyl)methyl]-5-(1-fluoroethenyl)-3,3-dimethyl-4-[(Z)-prop-1-enyl]pyrrol-2-one (PubChem CID 143635734) has the molecular formula C21H23F2NO3 and a molecular weight of 375.42 g/mol. Its IUPAC name is 1-[1,3-dioxolan-4-yl-(3-fluorophenyl)methyl]-5-(1-fluoroethenyl)-3,3-dimethyl-4-[(Z)-prop-1-enyl]pyrrol-2-one.
Molecular Properties
| Compound Name | 1-[1,3-dioxolan-4-yl-(3-fluorophenyl)methyl]-5-(1-fluoroethenyl)-3,3-dimethyl-4-[(Z)-prop-1-enyl]pyrrol-2-one |
|---|---|
| PubChem CID | 143635734 |
| Molecular Formula | C21H23F2NO3 |
| Molecular Weight | 375.42 g/mol |
| Exact Mass | 375.16 |
| IUPAC Name | 1-[1,3-dioxolan-4-yl-(3-fluorophenyl)methyl]-5-(1-fluoroethenyl)-3,3-dimethyl-4-[(Z)-prop-1-enyl]pyrrol-2-one |
| SMILES | C=C(F)C1=C(/C=C\C)C(C)(C)C(=O)N1C(c1cccc(F)c1)C1COCO1 |
| InChI | InChI=1S/C21H23F2NO3/c1-5-7-16-18(13(2)22)24(20(25)21(16,3)4)19(17-11-26-12-27-17)14-8-6-9-15(23)10-14/h5-10,17,19H,2,11-12H2,1,3-4H3/b7-5- |
| InChIKey | HZSGGGXMCLQDAY-ALCCZGGFSA-N |
| XLogP | 4.42 |
| TPSA | 38.77 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 375.42 |
| LogP ≤ 5 | 4.42 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143635734 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.